Pathology-related troponin I release and clinical outcome after pediatric open heart surgery

Paul Modi1, Hajime Imura, Gianni D Angelini

  • 1Bristol Heart Institute, University of Bristol, Bristol, UK.

Insights

Troponin I (TnI) release after pediatric heart surgery varies by defect type and incision length. Higher TnI levels correlate with longer recovery, indicating myocardial damage from surgery.

Area of Science:

  • Pediatric Cardiology
  • Cardiac Surgery
  • Biomarkers

Background:

  • Perioperative myocardial injury is influenced by ischemia duration, pathology, and preoperative status.
  • Troponin I (TnI) is a sensitive marker for myocardial injury.

Purpose of the Study:

  • To assess pathology-specific differences in TnI release after pediatric open-heart surgery.
  • To correlate TnI release with clinical outcomes.

Main Methods:

  • Serial postoperative TnI measurements in 133 children undergoing atrial septal defect (ASD), ventricular septal defect (VSD), or tetralogy of Fallot (TOF) repair.
  • Classification of right ventricular outflow tract (RVOT) incision length in TOF patients (minimum vs. extended).

Main Results:

  • TnI levels were defect-specific; no correlation with outcome for ASDs.
  • Peak TnI correlated with inotropic duration, ventilation, and ICU stay for VSD and TOF.
  • Younger age (<1 year) in VSD and extended RVOT incision in TOF were linked to higher TnI release and worse outcomes.

Conclusions:

  • Postoperative TnI release is pathology-dependent.
  • TnI reflects myocardial damage from ischemia-reperfusion and direct trauma.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...